Lifestyle and Metabolic Syndrome: Contribution of the Endocannabinoidome
Open accessThe DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
Lifestyle is a well-known environmental factor that plays a major role in facilitating the development of metabolic syndrome or eventually exacerbating its consequences. Various lifestyle factors, especially changes in dietary habits, extreme temperatures, unusual light–dark cycles, substance abuse, and other stressful factors, are also established modifiers of the endocannabinoid system and its extended version, the endocannabinoidome. The endocannabinoidome is a complex lipid signaling system composed of a plethora (>100) of fatty acid-derived mediators and their receptors and anabolic and catabolic enzymes (>50 proteins) which are deeply involved in the control of energy metabolism and its pathological deviations. A strong link between the endocannabinoidome and another major player in metabolism and dysmetabolism, the gut microbiome, is also emerging. Here, we review several examples of how lifestyle modifications (westernized diets, lack or presence of certain nutritional factors, physical exercise, and the use of cannabis) can modulate the propensity to develop metabolic syndrome by modifying the crosstalk between the endocannabinoidome and the gut microbiome and, hence, how lifestyle interventions can provide new therapies against cardiometabolic risk by ensuring correct functioning of both these systems.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor
Devane, W. A., Hanuš, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A., & Mechoulam, R. (1992) · Science · doi:10.1126/science.1470919 · Cited by 5,633
Cani, P. D., Bibiloni, R., Knauf, C., Waget, A., Neyrinck, A. M., Delzenne, N. M., & Burcelin, R. (2008) · Diabetes · doi:10.2337/db07-1403 · Cited by 4,819 · cited 1×
“The term “leaky gut” has been used to describe the phenomenon in which the tight junctions within the intestinal epithelial lining are compromised, leading to the movement of bacterially derived LPS into circulation, resulting in metabolic endotoxemia-induced inflammation that is associated with obesity [84,85].”
BackgroundCross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity
Everard, A., Belzer, C., Geurts, L., Ouwerkerk, J. P., Druart, C., Bindels, L. B., Guiot, Y., Derrien, M., Muccioli, G. G., Delzenne, N. M., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1219451110 · Cited by 4,511
Zhou, B., Lu, Y., Hajifathalian, K., Bentham, J., Di Cesare, M., Danaei, G., Bixby, H., Cowan, M., Ali, M., Taddei, C., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)00618-8 · Cited by 4,311
Gut Microbiota from Twins Discordant for Obesity Modulate Metabolism in Mice
Ridaura, V. K., Faith, J. J., Rey, F. E., Cheng, J., Duncan, A. E., Kau, A. L., Griffin, N. W., Lombard, V., Henrissat, B., Bain, J. R., et al. (2013) · Science · doi:10.1126/science.1241214 · Cited by 3,788
Mechoulam, R., Ben-Shabat, S., Hanus, L., Ligumsky, M., Kaminski, N. E., Schatz, A. R., Gopher, A., Almog, S., Martin, B. R., Compton, D. R., et al. (1995) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)00109-d · Cited by 2,913 · cited 1×
“Two small lipids ultimately derived from arachidonic acid, N-arachidonoylethanolamine (AEA or anandamide) and 2-arachidonoylglycerol (2-AG), were indeed identified and shown to be capable of high-affinity binding to both CB1 and CB2 receptors, stimulating their activity with good efficacy [26,27].”
BackgroundVitamin D deficiency: a worldwide problem with health consequences
Holick, M. F., & Chen, T. C. (2008) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/87.4.1080s · Cited by 2,689 · cited 1×
“Vitamin D deficiency represents a global health issue, with over a billion people being deficient [108], largely due to inadequate sun exposure.”
BackgroundCani, P. D., Possemiers, S., Van de Wiele, T., Guiot, Y., Everard, A., Rottier, O., Geurts, L., Naslain, D., Neyrinck, A., Lambert, D. M., et al. (2009) · Gut · doi:10.1136/gut.2008.165886 · Cited by 2,518 · cited 1×
“Supplementing the diets of genetically (ob/ob) or diet-induced obese mice with the prebiotic oligofructose increases Bifidobacterium species and Akkermansia muciniphila in association with improved gut barrier function and decreased inflammation [79,86,87].”
BackgroundDepommier, C., Everard, A., Druart, C., Plovier, H., Van Hul, M., Vieira-Silva, S., Falony, G., Raes, J., Maiter, D., Delzenne, N. M., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0495-2 · Cited by 2,357
Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides
Cravatt, B. F., Giang, D. K., Mayfield, S. P., Boger, D. L., Lerner, R. A., & Gilula, N. B. (1996) · Nature · doi:10.1038/384083a0 · Cited by 2,125
Exercise and associated dietary extremes impact on gut microbial diversity
Clarke, S. F., Murphy, E. F., O'Sullivan, O., Lucey, A. J., Humphreys, M., Hogan, A., Hayes, P., O'Reilly, M., Jeffery, I. B., Wood-Martin, R., et al. (2014) · Gut · doi:10.1136/gutjnl-2013-306541 · Cited by 1,439 · cited 1×
“In humans, studies on professional rugby players found that theirμBs were more diverse than sedentary controls and produced more short-chain fatty acids, though these changes were also associated with dietary differences [142,143].”
BackgroundBrain monoglyceride lipase participating in endocannabinoid inactivation
Dinh, T. P., Carpenter, D., Leslie, F. M., Freund, T. F., Katona, I., Sensi, S. L., Kathuria, S., & Piomelli, D. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.152334899 · Cited by 1,373
Mikkelsen, K., Stojanovska, L., Polenakovic, M., Bosevski, M., & Apostolopoulos, V. (2017) · Maturitas · doi:10.1016/j.maturitas.2017.09.003 · Cited by 1,072
Bisogno, T., Howell, F., Williams, G., Minassi, A., Cascio, M. G., Ligresti, A., Matias, I., Schiano-Moriello, A., Paul, P., Williams, E.-J., et al. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200305129 · Cited by 1,039
Polyunsaturated fatty acids in the food chain in the United States
Kris-Etherton, P., Taylor, D. S., Yu-Poth, S., Huth, P., Moriarty, K., Fishell, V., Hargrove, R. L., Zhao, G., & Etherton, T. D. (2000) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/71.1.179s · Cited by 1,023 · cited 1×
“Dietary linoleic acid (LA) is a major n-6 fatty acid component of Western diets, making up over 80% of the polyunsaturated fatty acid (PUFA) consumed in the United States [47], resulting in an imbalance the ratio of n-6/n-3 fatty acids consumed greatly in favor of the former.”
BackgroundDe Petrocellis, L., Ligresti, A., Moriello, A. S., Allarà, M., Bisogno, T., Petrosino, S., Stott, C. G., & Di Marzo, V. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01166.x · Cited by 946
Towards a more comprehensive concept for prebiotics
Bindels, L. B., Delzenne, N. M., Cani, P. D., & Walter, J. (2015) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2015.47 · Cited by 914 · cited 1×
“Increasing attention is being paid to “prebiotic” fiber, which is non-digestible by the host but is metabolized by gut microbiota, resulting in an alteration of the composition and/or activity of the μB, producing bioactive metabolites (such as short-chain fatty acids) that provide physiological benefits to the host […”
BackgroundImpact of Omega-3 Fatty Acids on the Gut Microbiota
Costantini, L., Molinari, R., Farinon, B., & Merendino, N. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18122645 · Cited by 741
The endocannabinoid system links gut microbiota to adipogenesis
Muccioli, G. G., Naslain, D., Bäckhed, F., Reigstad, C. S., Lambert, D. M., Delzenne, N. M., & Cani, P. D. (2010) · Molecular Systems Biology · doi:10.1038/msb.2010.46 · Cited by 691 · cited 15×
“Maternal exposure to high-fat diet also increased CB1 in the male, and CB2 in the female hypothalamus at birth, while CB1 and FAAH expression were increased, and CB2 and MGLL were decreased in the BAT of males and females, respectively.”
BackgroundInfluentialActivation of the peripheral endocannabinoid system in human obesity
Engeli, S., Böhnke, J., Feldpausch, M., Gorzelniak, K., Janke, J., Bátkai, S., Pacher, P., Harvey-White, J., Luft, F. C., Sharma, A. M., et al. (2005) · Diabetes · doi:10.2337/diabetes.54.10.2838 · Cited by 686 · cited 1×
“The observed increases in AEA and 2-AG levels appear to be due to changes in expression of adipose tissue-metabolizing enzymes, as the AEA-catabolizing enzyme FAAH was decreased and the 2-AG-anabolizing enzyme DAGLα was increased in the adipose tissue from obese individuals in conjunction with decreased CB1 expression…”
BackgroundBarton, W., Penney, N. C., Cronin, O., Garcia-Perez, I., Molloy, M. G., Holmes, E., Shanahan, F., Cotter, P. D., & O'Sullivan, O. (2018) · Gut · doi:10.1136/gutjnl-2016-313627 · Cited by 647
Longitudinal multi-omics of host–microbe dynamics in prediabetes
Zhou, W., Sailani, M. R., Contrepois, K., Zhou, Y., Ahadi, S., Leopold, S. R., Zhang, M. J., Rao, V., Avina, M., Mishra, T., et al. (2019) · Nature · doi:10.1038/s41586-019-1236-x · Cited by 583 · cited 1×
“Alterations in the μB are associated with other aspects of metabolic syndrome, including dyslipidemia, hypertension, and insulin resistance (reviewed extensively in [69–72]), and their consideration for the development of targeted therapies for “precision health” plans has recently been suggested for diabetes [73,74].”
BackgroundDietary fiber and health outcomes: an umbrella review of systematic reviews and meta-analyses
Veronese, N., Solmi, M., Caruso, M. G., Giannelli, G., Osella, A. R., Evangelou, E., Maggi, S., Fontana, L., Stubbs, B., & Tzoulaki, I. (2018) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqx082 · Cited by 536 · cited 1×
“The health benefits of dietary fiber have been extensively studied and reviewed, and there is little doubt that higher fiber is beneficial for cardiovascular disease, supporting prevalent recommendations that fiber intake be increased in order to maintain a healthy diet [81].”
BackgroundMailing, L. J., Allen, J. M., Buford, T. W., Fields, C. J., & Woods, J. A. (2019) · Exercise and Sport Sciences Reviews · doi:10.1249/jes.0000000000000183 · Cited by 521
Commensal bacteria make GPCR ligands that mimic human signalling molecules
Cohen, L. J., Esterhazy, D., Kim, S.-H., Lemetre, C., Aguilar, R. R., Gordon, E. A., Pickard, A. J., Cross, J. R., Emiliano, A. B., Han, S. M., et al. (2017) · Nature · doi:10.1038/nature23874 · Cited by 500 · cited 1×
“This evidence is reinforced by the recent finding that some commensal bacteria produce endocannabinoid-like compounds able to activate the same receptors as their host cell counterparts [17].”
BackgroundA Longitudinal Big Data Approach for Precision Health
Schüssler-Fiorenza Rose, S. M., Contrepois, K., Moneghetti, K. J., Zhou, W., Mishra, T., Mataraso, S., Dagan-Rosenfeld, O., Ganz, A. B., Dunn, J., Hornburg, D., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0414-6 · Cited by 494 · cited 1×
“Alterations in the μB are associated with other aspects of metabolic syndrome, including dyslipidemia, hypertension, and insulin resistance (reviewed extensively in [69–72]), and their consideration for the development of targeted therapies for “precision health” plans has recently been suggested for diabetes [73,74].”
BackgroundEstaki, M., Pither, J., Baumeister, P., Little, J. P., Gill, S. K., Ghosh, S., Ahmadi-Vand, Z., Marsden, K. R., & Gibson, D. L. (2016) · Microbiome · doi:10.1186/s40168-016-0189-7 · Cited by 476
Heyman, E., Gamelin, F.-X., Goekint, M., Piscitelli, F., Roelands, B., Leclair, E., Di Marzo, V., & Meeusen, R. (2012) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2011.09.017 · Cited by 427 · cited 1×
“showed that similar to AEA, PEA and OEA also increase during and after exercise and, in fact, are more responsive to lower intensity exercise than AEA [126].”
Jourdan, T., Godlewski, G., Cinar, R., Bertola, A., Szanda, G., Liu, J., Tam, J., Han, T., Mukhopadhyay, B., Skarulis, M. C., et al. (2013) · Nature Medicine · doi:10.1038/nm.3265 · Cited by 388 · cited 1×
“Thus, CB1 regulation of gut permeability, under the influence of the μB, is another mechanism by which CB1 regulates inflammation in addition to direct proinflammatory effects such as, for example, the stimulation of proinflammatory cytokine release from macrophages, which has developmental consequences for type 2 dia…”
BackgroundPrecup, G., & Vodnar, D.-C. (2019) · British Journal of Nutrition · doi:10.1017/s0007114519000680 · Cited by 378 · cited 1×
“The role of the Prevotella genus in metabolic health is complicated, due likely to the genetic diversity between individual species and, thus, several conflicting studies exist on its association with obesity, diabetes, and NAFLD, while others report positive correlations with improvements in various metabolic paramet…”
BackgroundEndocannabinoids–at the crossroads between the gut microbiota and host metabolism
Cani, P. D., Plovier, H., Van Hul, M., Geurts, L., Delzenne, N. M., Druart, C., & Everard, A. (2016) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2015.211 · Cited by 367 · cited 1×
“Thus, it appears that μB alterations in response to high-fat diets impacts upon the intestinal eCBome directly which, under obesity-inducing conditions, increases gut barrier permeability, subsequently resulting in increased circulating bacterially derived lipopolysaccharide (LPS) that subsequently modulates adipose t…”
BackgroundA Taxonomic Signature of Obesity in the Microbiome? Getting to the Guts of the Matter
Finucane, M. M., Sharpton, T. J., Laurent, T. J., & Pollard, K. S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0084689 · Cited by 321 · cited 1×
“The μB responds quickly to dietary interventions [66], and westernized diets are linked to dysbiosis (an imbalance of microbial communities) and associated with obesity, which is generally characterized by decreased bacterial diversity with an increase in the Firmicutes/Bacteroidetes phyla ratio [67,68].”
BackgroundExercise induction of gut microbiota modifications in obese, non-obese and hypertensive rats
Petriz, B. A., Castro, A. P., Almeida, J. A., Gomes, C. P., Fernandes, G. R., Kruger, R. H., Pereira, R. W., & Franco, O. L. (2014) · BMC Genomics · doi:10.1186/1471-2164-15-511 · Cited by 293 · cited 1×
“found that moderate exercise differentially changes the μB in wild type Wistar, obese Zucker, and spontaneously hypertensive rats, suggesting that exercise-induced changes in the μB may be dependent on the metabolic state of the host organism [138].”
BackgroundSystematic review: human gut dysbiosis induced by non-antibiotic prescription medications
Le Bastard, Q., Al‐Ghalith, G. A., Grégoire, M., Chapelet, G., Javaudin, F., Dailly, E., Batard, E., Knights, D., & Montassier, E. (2018) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.14451 · Cited by 263
Denou, E., Marcinko, K., Surette, M. G., Steinberg, G. R., & Schertzer, J. D. (2016) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00537.2015 · Cited by 260
Munukka, E., Ahtiainen, J. P., Puigbó, P., Jalkanen, S., Pahkala, K., Keskitalo, A., Kujala, U. M., Pietilä, S., Hollmén, M., Elo, L., et al. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.02323 · Cited by 237 · cited 1×
“muciniphila [145], which has been shown to increase the levels of eCBome monoacylglycerols, including 2-AG [87] and, as mentioned above, to be regulated by both CB1 and TRPV1 activity [21,103].”
BackgroundRossmeisl, M., Macek Jilkova, Z., Kuda, O., Jelenik, T., Medrikova, D., Stankova, B., Kristinsson, B., Haraldsson, G. G., Svensen, H., Stoknes, I., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038834 · Cited by 230 · cited 2×
“In support of this, n-3 PUFAs provided as phospholipids, rather than free fatty acids, result in more significant decreases in eCB levels [12,52].”
BackgroundDehghan, P., Pourghassem Gargari, B., & Asghari Jafar-abadi, M. (2014) · Nutrition · doi:10.1016/j.nut.2013.09.005 · Cited by 207 · cited 1×
“Similarly, women with type 2 diabetes who were given oligofructose-enriched inulin (10 g/day) for 8 weeks had significantly lower circulating levels of LPS and other inflammatory markers, along with decreased fasting glucose and glycosylated hemoglobin [88].”
BackgroundEsteve, E., Ricart, W., & Fernández-Real, J.-M. (2011) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0b013e328348c06d · Cited by 133
Perez‐Burgos, A., Wang, L., McVey Neufeld, K., Mao, Y., Ahmadzai, M., Janssen, L. J., Stanisz, A. M., Bienenstock, J., & Kunze, W. A. (2015) · The Journal of Physiology · doi:10.1113/jp270229 · Cited by 123 · cited 1×
“In fact, the visceral antinociceptive effects of the probiotic Lactobacillus reuteri has been attributed to inhibition of TRPV1 activity in mesenteric neurons [107], indicating also that the eCBome may play a significant role in mediating the activity of microbial influences on the gut–brain axis, at least with respec…”
BackgroundHalcox, J. P., Banegas, J. R., Roy, C., Dallongeville, J., De Backer, G., Guallar, E., Perk, J., Hajage, D., Henriksson, K. M., & Borghi, C. (2017) · BMC Cardiovascular Disorders · doi:10.1186/s12872-017-0591-5 · Cited by 122 · cited 1×
“A plethora of epidemiological studies point to these aspects as major predictors of various forms of dysmetabolism, including obesity and visceral adipose tissue accumulation [2], glucose intolerance, pre-diabetes and type 2 diabetes [3], dyslipidemia [4], hypertension [5] and, eventually, the development of atherogen…”
Background
Cited by
Metabolic Syndrome: Past, Present and Future
Lemieux, I., & Després, J.-P. (2020) · Nutrients · doi:10.3390/nu12113501 · Cited by 309
ω-3 and ω-6 Polyunsaturated Fatty Acids, Obesity and Cancer
D’Angelo, S., Motti, M. L., & Meccariello, R. (2020) · Nutrients · doi:10.3390/nu12092751 · Cited by 250
Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years
Maccarrone, M., Di Marzo, V., Gertsch, J., Grether, U., Howlett, A. C., Hua, T., Makriyannis, A., Piomelli, D., Ueda, N., & van der Stelt, M. (2023) · Pharmacological Reviews · doi:10.1124/pharmrev.122.000600 · Cited by 183
Role of the endocannabinoid system in the regulation of intestinal homeostasis
Cuddihey, H., MacNaughton, W. K., & Sharkey, K. A. (2022) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2022.05.015 · Cited by 79
Metadata
- Authors
- Di Marzo, V., & Silvestri, C.
- Venue
- Nutrients
- Publisher
- MDPI AG
- Published
- 2019-08-20
- Volume
- 11
- Issue
- 8
- Pages
- 1956
- ISSN
- 2072-6643 (ISSN-L)
- OpenAlex
- W2969389949
- Cited by
- 135
- References
- 41
- FWCI
- 9.01
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.